AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Bicycle Therapeutics plc
$3.66
-$3.02 (-45.21%)
Previous Close
$3.82
Day Range
$3.60$3.80
Year Range
$3.33$8.11
Market Cap
256.17M
AVG Volume
407.87K
Trailing/Forward PE
-1.8/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2027-03-02
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: BCYC
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Mar 2027.
Video analysis: BCYC
All videosNo video analysis for this stock yet. Request one from our team.
News: BCYC
Similar companies
-
Neumora Therapeutics, Inc. Common Stock
NMRA
·
NASDAQ
Compare
-
Omeros Corporation
OMER
·
NASDAQ
Compare
-
Lexicon Pharmaceuticals, Inc.
LXRX
·
NASDAQ
Compare
-
ADC Therapeutics S.A.
ADCT
·
New York Stock Exchange
Compare
-
Prothena Corporation plc
PRTA
·
NASDAQ
Compare
-
4D Molecular Therapeutics, Inc.
FDMT
·
NASDAQ
Compare